Ferring Pharmaceuticals has successfully finalised a Mutual…
The Ferring Innovation Grants Program, which is now open for applications, has been significantly expanded as part of Ferring’s continued commitment to investing in research and development…
To mark World IBD Day 2016, Ferring Pharmaceuticals and North Zealand University Hospital in Copenhagen…
Ferring Pharmaceuticals today announced that NOCDURNA® (desmopressin) has received approval in the EU…
The future of the Earth’s poles is critical. In the coming decades, major international negotiations will focus on the polar regions, which are bearing…
Today is ‘World Sleep Day’ which was initiated by the World Association of Sleep Medicine (WASM) to acknowledge the importance of a…
The new Ferring Asia-Pacific Regional Headquarters focuses on supply chain planning and coordination to support the growth of emerging markets…
In collaboration with Ferring Pharmaceuticals, Merck and Supply Chain Operations SA…
Ferring Pharmaceuticals announced today the commencement of the Phase 3b PRONOUNCE Trial. The trial will compare the occurrence of major…
Ferring Pharmaceuticals and Karolinska Institutet announce today that a collaboration agreement has been signed for the establishment of a…
This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.
OKCette page n'est pas destinée aux patients ou au grand public. Il est uniquement destiné à être utilisé par des professionnels de santé.
OKIk bevestig dat ik een professionele zorgverlener ben of een zakelijke relatie heb met Ferring Pharmaceuticals
OKEz az oldal nem betegeknek, vagy nagyközönségnek szól. Az oldalt kizárólag egészségügyi szakemberek használhatják.
OKTa strona nie jest przeznaczona dla pacjentów ani dla ogółu odwiedzających. Ta strona stworzona jest dla pracowników sektora ochrony zdrowia.
OKЭта страница не предназначена для пациентов или для широкой публики. Она предназначена только для медицинских работников.
OK